logo

For the Inventor, By the Inventor

Tokyo, Japan

Haruhisa Hirata

This inventor holds 5 USPTO granted patents. Top assignee: Wakamoto Pharmaceutical Co., Ltd.. Active years: 1989-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Haruhisa Hirata. Retrieved from https://idiyas.com/inventor/haruhisa-hirata

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 100.0

Average Co-Inventor Count = 4.2

ph-index = 3

Forward Citations = 23(Granted Patents)


Location History:

  • Osaka, JP (1989)
  • Tokyo, JP (1997 - 2006)

Company Filing History:

goldMedal5 out of 39 
 
Wakamoto Pharmaceutical Co., Ltd.
 patents

Years Active: 1989-2006

Loading Chart...
5 patents (USPTO):Explore Patents
1. 7150986 - Lactic acid bacteria-containing probiotics products (2006-12-19),
2. 6849419 - Monoclonal antibody hybridoma immunoassay method and diagnosis kit (2005-02-01),
3. 6777197 - Method and test kit for measuring immunoglobulins reactive with amylase as indication of crohn's disease (2004-08-17),
4. 5648455 - Antibiotic WAP-8294A, method for preparing the same and antibacterial (1997-07-15),
5. 4861718 - Gene coding for thermostable beta-galactosidase, bacillus subtilis (1989-08-29),

Title: Haruhisa Hirata: Innovator in Probiotics and Diagnostic Methods

Introduction

Haruhisa Hirata is a notable inventor based in Tokyo, Japan. He has made significant contributions to the fields of probiotics and diagnostic methods, holding a total of 5 patents. His work focuses on developing innovative solutions that enhance health and medical diagnostics.

Latest Patents

Hirata's latest patents include a range of groundbreaking inventions. One of his notable inventions is a probiotics product that contains lactic acid bacteria with high adhesiveness to mucous membranes, high proliferation ability, and resistance to acids. This product aims to prevent and treat diseases of the digestive tract effectively. Another significant patent is a monoclonal antibody hybridoma immunoassay method and diagnosis kit. This diagnostic method allows for low-cost infection diagnosis without causing pain to subjects and is characterized by its specificity and sensitivity.

Career Highlights

Hirata is currently associated with Wakamoto Pharmaceutical Co., Ltd., where he continues to innovate in the field of health and medicine. His work has been instrumental in advancing the understanding and application of probiotics and diagnostic technologies.

Collaborations

Hirata has collaborated with notable colleagues, including Ritsuko Mochida and Seigo Nakaya. Their combined expertise has contributed to the success of various projects and patents.

Conclusion

Haruhisa Hirata's contributions to probiotics and diagnostic methods highlight his role as a leading inventor in Japan. His innovative patents continue to impact health and medical diagnostics positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…